Medtech Archives - Page 58 of 107

Orbital Therapeutics Names Adam Raff, M.D., Ph.D., Senior Vice President of Clinical Development

September 4, 2025

Treeline Biosciences Launches First Clinical Trials and Expands Funding to $1.1 Billion

September 3, 2025

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Facility

September 2, 2025

THIS WEEK'S STORIES

Vyome Reports Positive Interim Phase 2 Data for VT-1953 in Malignant Fungating Wounds, Eyes $1B U.S. Market Opportunity

September 4, 2025

Atlas Venture Closes $400 Million Third Opportunity Fund to Back Growth of Biotech Portfolio

September 4, 2025

BostonGene Study in Cell Reports Medicine Highlights Multimodal AI to Predict Immunotherapy and VEGF Inhibitor Outcomes in Kidney Cancer

September 2, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

HealthEdge and UST HealthProof Merge to Create AI-Powered Healthcare Payer Technology Leader Under Bain Capital Ownership

Kerecis Showcases Fish-Skin Graft Technology at SAWC Fall 2025 in Las Vegas

Vyome Partners with Embryyo to Target AI-Enabled Medical Device Market

Pleural Dynamics Completes Patient Enrollment in Study of Novel Pleural Effusion Device

PECA Labs’ Dr. Arush Kalra Named to Pittsburgh’s 40 Under 40

Most Read

Deborah Gracio Named Director of Pacific Northwest National Laboratory

Ibex Medical Analytics Earns IVDR Certification for AI-Powered HER2 Breast Cancer Scoring Solution

Pridopidine Shows Promise in Early Huntington’s Disease, Nature Medicine Publishes Phase 3 Data

Ametros Brings Back Shawn Deane as General Counsel

EDITOR PICKS

Orbital Therapeutics Names Adam Raff, M.D., Ph.D., Senior Vice President of Clinical Development

Treeline Biosciences Launches First Clinical Trials and Expands Funding to $1.1 Billion

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Facility

THIS WEEK'S STORIES

Vyome Reports Positive Interim Phase 2 Data for VT-1953 in Malignant Fungating Wounds, Eyes $1B U.S. Market Opportunity

Atlas Venture Closes $400 Million Third Opportunity Fund to Back Growth of Biotech Portfolio

BostonGene Study in Cell Reports Medicine Highlights Multimodal AI to Predict Immunotherapy and VEGF Inhibitor Outcomes in Kidney Cancer

POPULAR CATEGORY

ABOUT US

FOLLOW US